In fact, it matters more
doi: 10.1016/j.clinre.2016.11.009 Summary Keywords glucagon-like peptide-1 receptor agonists, metabolic disease, metabolic dysfunction-associated steatotic liver disease, public health, umbrella review Citation Wu H, Zhang Z-H, Ye T, Chen J-N, Tung T-H and Zhu J-S (2026) Efficacy and safety of GLP-1 receptor agonists in patients with metabolic-associated fatty liver diseases: an umbrella review
This comprehensive approach ensures both safety and effectiveness
Hydration and Side Effect Management Travel can be dehydrating, and GLP-1 medications already require high water intake to mitigate side effects like nausea or fatigue
Conclusion There has been clear evidence in vitro, in rodents and in humans, that obesity and inflammation are significantly interconnected and effect each other on several metabolic levels
Patients should be advised to eat smaller, more frequent meals rather than large meals that can overload the stomach and exacerbate heartburn symptoms